NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair, CEO and 10% owner Ron Bentsur bought $28K of Nuvectis Pharma, Inc.
Bought$28,200
$7.05Price
4,000Shares
What NVCT did for a copier
- $1,000 copied at Tue, Mar 29 open, $7.50
- $2,116
- S&P 500, same days
- −14.6%
Measured over 30 trading days, to the May 11 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +53.0% against the S&P 500, and 7 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Mar 28. Filed Tue, Mar 29, 4:31 AM ET, before the open. Returns use the Mar 29 open and the May 11 close. Not investment advice.